芬太尼与雾化氯胺酮用于院前镇痛:一项回顾性数据回顾
本研究为回顾性横断面评估,纳入2022年3月1日至2023年6月1日某大型郊区急救系统内接受芬太尼或经呼吸驱动雾化器(BAN)给氯胺酮镇痛的1480例患者,芬太尼组1317例(89.0%)、氯胺酮组163例(11.0%)。主要终点为首次至末次疼痛评分变化,总体未校正均值芬太尼组-2.9(SD 3.0)、氯胺酮组-3.5(SD 3.4);倾向评分分析显示总体无统计学显著差异(IPTW均值差-0.45,95%CI -1.18, 0.28;PSM -0.36,95%CI -0.93, 0.21)。创伤痛亚组中氯胺酮较芬太尼显著降低疼痛(未校正-1.37,95%CI -2.20, -0.54;IPTW -1.10,95%CI -1.96, -0.23;PSM -0.92,95%CI -1.17, -0.12)。作者认为经BAN给氯胺酮因给药便捷且无需静脉通路,是院前镇痛合理有效的选择。
要点
- 院前总体人群:芬太尼与BAN氯胺酮镇痛评分变化无统计学显著差异(IPTW均值差-0.45,95%CI -1.18, 0.28;PSM -0.36,95%CI -0.93, 0.21)。
- 创伤痛亚组:氯胺酮较芬太尼显著降低疼痛评分(未校正-1.37,95%CI -2.20, -0.54;IPTW -1.10,95%CI -1.96, -0.23;PSM -0.92,95%CI -1.17, -0.12)。
- 未校正疼痛评分变化:芬太尼组-2.9(SD 3.0) vs 氯胺酮组-3.5(SD 3.4)。
- 作者认为经BAN给氯胺酮因给药便捷且无需静脉通路,是院前镇痛的合理有效选择。
适用人群与场景
- 2022年3月1日至2023年6月1日某大型郊区急救系统内接受芬太尼或经呼吸驱动雾化器(BAN)给氯胺酮进行疼痛管理的院前患者,共1480例;芬太尼组1317例(89.0%),氯胺酮组163例(11.0%)。
- 亚组分析针对创伤性疼痛患者。
研究设计与关键结果
- 研究类型:回顾性横断面评估;样本量1480例;人群为大型郊区急救系统院前疼痛管理患者;干预为芬太尼 vs 经BAN给氯胺酮;主要终点为首次至末次疼痛评分变化。
- 未校正疼痛评分平均变化:芬太尼组-2.9(SD 3.0) vs 氯胺酮组-3.5(SD 3.4)。
- 总体倾向评分分析:芬太尼 vs 氯胺酮疼痛评分变化无统计学显著差异(IPTW均值差-0.45,95%CI -1.18, 0.28;PSM均值差-0.36,95%CI -0.93, 0.21)。
- 创伤痛亚组:氯胺酮较芬太尼显著降低疼痛评分(未校正-1.37,95%CI -2.20, -0.54;IPTW -1.10,95%CI -1.96, -0.23;PSM -0.92,95%CI -1.17, -0.12)。
证据类型、等级与局限
- 证据类型:回顾性横断面研究;采用逆概率治疗加权(IPTW)和倾向评分匹配(PSM)估计治疗效果。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为经BAN给氯胺酮因给药便捷且无需静脉通路,是院前疼痛管理的合理有效选择。
- 总体院前疼痛人群中芬太尼与BAN氯胺酮镇痛效果无统计学显著差异;创伤性疼痛患者中BAN氯胺酮镇痛效果优于芬太尼。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: To evaluate the comparative effectiveness of fentanyl and ketamine via Breath Actuated Nebulizer (BAN) for analgesia in the prehospital setting.
METHODS: We conducted a retrospective cross-sectional evaluation of patients receiving fentanyl or ketamine via BAN for pain management in a large suburban EMS system between 3/1/2022 and 6/1/2023. The primary outcome was change in first to last pain score. Subgroup analysis was performed on patients with traumatic pain. We used inverse probability of treatment weighting (IPTW) and propensity score matching (PSM) to estimate the treatment effect of fentanyl vs ketamine via BAN among all patients and the subgroup of those with traumatic pain.
RESULTS: Of the total 1480 patients included, 1317 (89.0 %) received fentanyl and 163 (11.0 %) received ketamine via BAN. The unadjusted mean change in pain score was -2.9 (SD 3.0) for fentanyl and -3.5 (SD 3.4) for ketamine. In the propensity score analyses, there was no statistically significant difference in pain score change for the fentanyl group versus ketamine among all patients (mean difference, IPTW: -0.45, 95 %CI -1.18, 0.28; PSM: -0.36, 95 %CI -0.93, 0.21). Subgroup analysis of patients treated for traumatic pain showed a significant reduction in pain for patients treated with ketamine compared to fentanyl, indicating a higher degree of analgesia from ketamine for traumatic pain (unadjusted: -1.37, 95 % CI -2.20, -0.54; IPTW: -1.10, 95 % CI -1.96, -0.23; PSM: -0.92, 95 % CI -1.17, -0.12).
CONCLUSION: We found no statistically significant difference in the analgesic treatment effect for the overall fentanyl and ketamine groups. Subgroup analysis of patients treated for traumatic pain showed greater analgesia for ketamine via BAN over fentanyl. Given the ease of administration and lack of need for intravenous access, ketamine via BAN is a reasonable and effective choice for prehospital pain management.
参考来源
- McArthur R, Cash RE, Anderson J, et al. Fentanyl versus nebulized ketamine for prehospital analgesia: A retrospective data review. Am J Emerg Med. 2024. PMID: 39708459. doi:10.1016/j.ajem.2024.12.033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。